BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren J, Lan T, Liu T, Liu Y, Shao B, Men K, Ma Y, Liang X, Wei YQ, Luo M, Wei XW. CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis. J Immunol 2022;208:2425-35. [PMID: 35437281 DOI: 10.4049/jimmunol.2100341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Aru B, Pehlivanoğlu C, Dal Z, Dereli-Çalışkan NN, Gürlü E, Yanıkkaya-Demirel G. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia. Front Immunol 2023;14:1108200. [PMID: 36742324 DOI: 10.3389/fimmu.2023.1108200] [Reference Citation Analysis]
2 Hossain SM, Gimenez G, Stockwell PA, Tsai P, Print CG, Rys J, Cybulska-stopa B, Ratajska M, Harazin-lechowska A, Almomani S, Jackson C, Chatterjee A, Eccles MR. Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures. Front Immunol 2022;13:955063. [DOI: 10.3389/fimmu.2022.955063] [Reference Citation Analysis]
3 Palaniappan A, Sarathi A. A comprehensive algorithmic dissection yields biomarker discovery and insights into the discrete stage-wise progression of colorectal cancer.. [DOI: 10.1101/2022.08.16.22278877] [Reference Citation Analysis]